New World Health Organization (WHO) guidelines for the treatment of drug resistant tuberculosis (DR-TB) are shaping as a game changer for the estimated 500,000 people diagnosed with DR-TB each year, and the longer-term goal ...
Mar 24, 2023
0
31
Volodymyr is celebrating a major milestone on Wednesday—it's his final day of taking a new treatment hailed as a turning point in the fight against drug-resistant tuberculosis.
Sep 1, 2022
0
47
A massive analysis of more than 10,000 different Mycobacterium tuberculosis bacteria isolates from 23 countries has revealed new genes associated with resistance to 13 first- and second-line new and repurposed antibiotics. ...
Aug 10, 2022
0
124
Tuberculosis (TB) continues to be one of the top ten leading causes of death worldwide, with more than 1.3 million reported deaths in 2020. The emergence and spread of drug-resistant forms of the disease have complicated ...
Jun 30, 2022
0
63
Early success with Nigeria's implementation of the new and shorter six-month tuberculosis treatment regimen in four states could pave the way for its rollout nationwide, says an expert.
Jun 13, 2022
0
5
Tuberculosis is a major public health concern, an ancient bacterial disease that has claimed the lives of kings, presidents, poets and at least one star of Hollywood's silver screen-era. Yet even now in the 21st century, ...
To many, tuberculosis (TB) may seem like a disease from a bygone era. But it still claims more than one million lives every year. And the problem is growing worse as Mycobacterium tuberculosis, the pathogen that causes TB, ...
May 9, 2022
0
86
The COVID-19 pandemic continues, but there is another global infectious disease that has a huge impact on the world. Tuberculosis (TB) causes over 1.5 million deaths and over 10 million infections per year. Estimates suggest ...
Mar 23, 2022
0
7
Public health experts are getting a better picture of drug-resistant tuberculosis in Moldova, thanks to the efforts of a coalition of researchers from across the world led by scientists at the Yale School of Public Health.
Mar 14, 2022
0
42
A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced at the 52nd Union World ...
Oct 20, 2021
0
5
